Lemonade earnings beat by $0.02, revenue topped estimates

Lemonade (LMND) reported Q3 EPS of -$0.56, beating estimates by $0.02, with revenue of $336.1M, exceeding expectations. The company guided Q4 2026 revenue to $342M-$346M and FY 2026 revenue to $1.23B-$1.24B. LMND's stock is down 13.30% over 3 months and 38.91% over 12 months.

Original reporting
Published Nov 5, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 11:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$LMND
Neutral
high confidence
Mentioned
$LMND
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$LMNDNeutralMed
01

Why it matters

The earnings beat may provide short‑term support, but guidance near consensus limits long‑term upside.

02

Market read

Earnings release provides fresh data for traders; modest beat may prompt short‑term positioning.

03

What to watch

Potential upside if the company can improve loss ratios or expand distribution channels.

Relevance 7/10Novelty 7/10Timing: post-market today

Background

Lemonade is a digital insurer that recently posted a loss but showed revenue growth.

Company-level read

Ticker impact

$LMNDNeutralHigh confidence
Context

LMND reported Q3 EPS of -$0.56 beating estimates by $0.02 and revenue of $336.1M above consensus.

Expected impact

likely modest pressure as market prices in guidance that matches expectations

Evidence & confidence

The beat is small and guidance is close to consensus, so traders may see limited upside.

Market effects

Insurance tech sector may see slight re‑rating as LMND's results suggest modest growth.

U.S. market may see limited ripple as the beat is narrow.

Low global impact; primarily relevant to U.S. investors.

Counterpoint

Despite the beat, the narrow margin and flat guidance could signal underlying weakness.

Key entities

  • Lemonade

    Digital insurer listed on NYSE under ticker LMND.

Related articles

$LMNDMed

Lemonade stock price target lowered to $45 by Keefe Bruyette

Keefe Bruyette & Woods lowered its price target on Lemonade Inc. (NYSE:LMND) to $45 from $48, citing higher growth spending and operating expenses. The firm noted Lemonade's premium growth exceeds 30% and revenue grew nearly 70% in the last twelve months. Lemonade reported Q3 2026 earnings, exceeding expectations with revenue of $336.1 million and adjusted loss of $0.56 per share.

$LMNDMed

Lemonade Q3 Earnings Call Highlights

Lemonade (LMND) reported Q3 operating expenses rose 36% YoY, driven by higher sales and marketing, and administrative costs. Adjusted free cash flow was $27M, with $1.2B in cash. Lemonade Car's premium grew 63% YoY, and the company expects slower growth spending. Loss ratios varied by product, with pet insurance under pressure. The company plans to discuss AI initiatives at its investor day.

$LMNDHighAI 8/10

Lemonade (LMND) Q3 2026 Earnings Call Transcript

Lemonade (LMND) reported Q3 2026 results: $1.55B in-force premium (+34%), $336.1M revenue (+73%), $118.1M gross profit (+48%), and $20.4M adjusted EBITDA loss (improved from prior year). Customer base grew 23% to 3.5M, with premium per customer up 9% to $440. Gross loss ratio increased to 65% due to inflation and weather events. Management expects Q4 adjusted EBITDA to be positive and full-year revenue between $1.23B and $1.235B.

$LMNDMed

Lemonade Inc (LMND) (Q3 2026) Earnings Call Highlights: Record Premium Growth and a Clear

Lemonade Inc (LMND) reported Q3 2026 earnings, highlighting record premium growth and strategic advantages from AI agents. CEO Daniel Schreiber noted AI's potential to favor Lemonade over incumbents. CFO Tim Bixby discussed car insurance loss ratios, G&A expenses, and pet insurance trends. The company expects accelerated state rollouts and cross-sales growth, with no significant incremental customer acquisition costs for cross-sold products.